Replacing protein via enteral nutrition in a stepwise approach in critically ill patients: the REPLENISH randomized clinical trial protocol

Replacing protein via enteral nutrition in a stepwise approach in critically ill patients: the REPLENISH randomized clinical trial protocol

Abstract Background Protein intake is recommended in critically ill patients to mitigate the negative effects of critical illness-induced catabolism and muscle wasting. However, the optimal dose of enteral protein remains unknown. We hypothesize that supplemental enteral protein (1.2 g/kg/day) added...

Description complète

Détails bibliographiques
Auteurs principaux: Yaseen M. Arabi, Hasan M. Al-Dorzi, Musharaf Sadat, Dina Muharib, Haifa Algethamy, Fahad Al-Hameed, Ahmed Mady, Adnan AlGhamdi, Ghaleb. A. Almekhlafi, Abdulrahman A. Al-Fares, Ayman Kharaba, Ali Al Bshabshe, Khalid Maghrabi, Khalid Al Ghamdi, Ghulam Rasool, Jamal Chalabi, Haifaa Ibrahim AlHumedi, Maram Hasan Sakkijha, Norah Khalid Alamrey, Rabeah Hamad Alhutail, Kaouthar Sifaoui, Mohammed Almaani, Rakan Alqahtani, Ahmad S. Qureshi, Mohammed Moneer Hejazi, Hatim Arishi, Samah AlQahtani, Amro Mohamed Ghazi, Saleh T. Baaziz, Abeer Othman Azhar, Sara Fahad Alabbas, Mohammed AlAqeely, Ohoud AlOrabi, Aliaa Al-Mutawa, Maha AlOtaibi, Omar Aldibaasi, Jesna Jose, Joel Starkopf, Jean-Charles Preiser, Anders Perner, Abdulaziz Al-Dawood, the Saudi Critical Care Trials Group
Format: Article
Langue:English
Publié: BMC 2023-07-01
Collection:Trials
Sujets:
Critical illness
Protein intake
Randomized controlled trial
Mortality
Functional outcomes
Accès en ligne:https://doi.org/10.1186/s13063-023-07507-6

Internet

https://doi.org/10.1186/s13063-023-07507-6

Documents similaires